Artificial Intelligence, Machine Learning, and In Silico Tools
Carterra is enabling the next generation of AI-driven drug discovery by providing the high-quality, high-throughput experimental data needed to power Lab-in-the-Loop workflows. As AI and machine learning models generate increasingly large and complex sets of therapeutic candidates, Carterra’s high-throughput SPR platforms rapidly validate those designs in the wet lab—delivering rich, quantitative insights into binding kinetics, affinity, specificity, and epitope diversity at unprecedented scale.
These experimental data can then be fed back into AI models to inform and improve the next round of design, creating a continuous design–build–test–learn cycle that accelerates optimization and helps researchers identify better candidates faster. By bridging computational design with scalable, information-rich biology, Carterra provides a critical link between AI predictions and experimentally validated therapeutics.
Carterra Partnerships
Carterra is partnering with industry leaders and developing high-throughput biology tools advancing artificial intelligence (AI), machine learning (ML), and in silico workflows. Carterra’s HT-SPR instruments offer first-in-class throughput and speed, minimal sample usage, and the ability to analyze up to 150,000 interactions per assay. The LSA, LSAXT, Carterra Ultra®, and Carterra Vega™ are the only platforms that enable true AL/ML approaches to antibody design and characterization enabling scientists to speed up and optimize drug discovery workflows.
Partners:
 |
 |
 |
 |
 |
 |
Streamline your HT-Biology characterization process
Apply AI and ML to your High-Throughput Surface Plasmon Resonance (HT-SPR) data sets that are efficiently curated using partnered electronic lab notebook (ELN) and data management systems.
Key Benefits:
- More effective screening and selection of top candidates by deep learning of the data
- Better optimization of biotherapeutic candidates based on larger comparison of orthogonal characterization results
- Reduction of scientists’ hands-on time with AI/ML doing the analysis
- Curated results in one platform
- Comprehensive platform of instrument and software that seamlessly integrates into AI/ML workflows
“The Carterra LSA is the only instrument that can deliver high-resolution binding data at this level of throughput. The ability to collect data at such a high speed and volume has led the LSA to become an integral part of our machine learning-driven protein design platform.”
– Brett Blakeley, Senior Scientist, Generate Biomedicines
Data management
Revvity Signals VitroVivo Software
In collaboration with Revvity, use Revvity’s Signals™ VitroVivo (formerly Signals Screening) software v2.7 or later to integrate the Carterra LSA, LSAXT, or Carterra Ultra HT-SPR data for further integration and analysis.
Key Benefits:
- Single repository to organize and document all HT-SPR experimental data for better data management
- Compare HT-SPR results to data obtained by other orthogonal methods, such as high content screening, alternative biochemical and biophysical screening methods, and in vivo studies
- Faster time to results with built-in intuitive data analysis and search tools
- More effective assay development with protocol and modeling tools to make more educated prediction and selection of candidates
- Comprehensive analytics through integration with TIBCO® Spotfire®
Learn More About Revvity Signals VitroVivo Software